Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 12 of 12 items.

" " DRAXIMAGE MDP: Affected lot may contain particulate matter
Affected lot may contain particulate matter  
RecallHealth product recall | 2022-08-30
" " NERFASIN 20: Affected lot may contain the presence of particles
Affected lot may contain the presence of particles
RecallHealth product recall | 2022-08-29
" " PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
" " Sodium Chloride Inj; Glass particles
The affected lots may contain glass particles.
RecallHealth product recall | 2022-08-02
" " Heparin Sodium and 0.9% Sodium Chloride Injection: leak in intravenous bag
Intravenous bag may be leaking in affected lot
RecallHealth product recall | 2022-03-07
" " 0.9% Sodium Chloride Injection USP: Leaking solution bag
 Solution bags may be leaking in affected lot.
RecallHealth product recall | 2022-02-28
" " APO-AMITRIPTYLINE 10mg: NDMA impurity
Affected lots exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint. 
RecallHealth product recall | 2022-01-26
" " ELAVIL 10mg: NDMA impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 36-month stability testing timepoint.
RecallHealth product recall | 2022-01-26
" " Piperacillin and Tazobactam for injection: Particulate
Visible particles observed in vials following reconstitution 
RecallHealth product recall | 2022-01-17
" " Acid Reducer (Ranitidine) Tablet: N-nitrosodimethylamine (NDMA) impurity
Presence of N-nitrosodimethylamine (NDMA) above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2021-12-03
" " Nerfasin 20: quality issue (presence of particles)
Affected lot may contain the presence of particles 
RecallHealth product recall | 2021-11-30
" " Dotarem Injection: Product Sterility
Product sterility may be compromised in the affected lot due to the possibility of defects in the vial.
RecallHealth product recall | 2021-11-22
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.